Back to News
Mergers & Acquisitions

DraftKings Hits Public Market With SPAC Merger

|
Published: June 22nd, 2020
The daily fantasy and sports betting company has agreed to a merger with special purpose acquisition company Diamond Eagle Acquisition.

Those betting DraftKings was due for the public markets may have just hit pay dirt.

The daily fantasy company and recent entrant in to the sports betting scene has agreed to a merger with special purpose acquisition company Diamond Eagle Acquisition Corp. that will bring the Boston-based company public.

As part of the deal, which will create a $3.3 billion-in-market-cap company, DraftKings will merge with SBTech, an online gaming platform that provides technology to sports books including Churchill Downs, Virgin Bet and Golden Nugget online casinos.

Editor’s note: The original version of this article, including advisers and other details, was published earlier on The Deal’s premium subscription website. For access, log in to TheDeal.com or use the form below to request a free trial.

This Content is Only for The Deal Subscribers

The Deal provides actionable, intraday coverage of mergers, acquisitions and all other changes in corporate control to institutional investors, private equity, hedge funds and the firms that serve them.

If you’re already a subscriber, log in to view this article here.

More From Mergers & Acquisitions

Mergers & Acquisitions

Drinks With The Deal: Squire Patton Boggs' James Barresi

By David Marcus
|
Published: November 18th, 2021
James Barresi, who heads the firm's financial services practice, explains how his time as an in-house lawyer at US Bancorp in the 1990s has shaped his approach to private practice and how he works with clients considering a deal.
Mergers & Acquisitions

Book Review: Consider the Cocktail

By David Marcus
|
Published: November 4th, 2021
The new 'Oxford Companion to Spirits & Cocktails' treats the beverages in all of their aspects from production to history to brand management.
Mergers & Acquisitions

Drinks With The Deal: Krishna Veeraraghavan of Paul Weiss

By David Marcus
|
Published: October 14th, 2021
M&A lawyer Krishna Veeraraghavan talked about healthcare dealmaking and the risks of excessive antitrust regulation of combinations between biotech and pharma companies in the Drinks With The Deal podcast.